A new lung cancer vaccine has been tested on a UK patient for the first time.
BNT116 is designed to treat non-small cell lung cancer - also known as NSCLC - the most common form of the disease.
Professor Siow Ming Lee, consultant medical oncologist at University College London Hospitals NHS Foundation Trust, and chief investigator for the trial in the UK, tells Tech & Science Daily how it works, and why this could be game changing for lung cancer patients around the globe.
If you're in London docklands this weekend, we'll tell you why you may see a 2.5-ton block of ice suspended from a crane. Joshua Thomson from Australian physical theatre company Legs On The Wall, discusses their new performance THAW by and why they hope to highlight the impact of climate change.
Also in this episode:
Follow us on X or on Threads.
","author_name":"The Evening Standard"}